Carcinoma, Non-Small-Cell Lung Clinical Trials

There are 13 registered clinical trials for Carcinoma, Non-Small-Cell Lung in the TrialLens index.

Trials (13)

• Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium N/A · AstraZeneca
• MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer Phase 2 · Pfizer
• Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma Phase 1 · Novartis Pharmaceuticals
• Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) Phase 2 · Lung Cancer Group Cologne
• Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer Phase 2 · Intergroupe Francophone de Cancerologie Thoracique
• Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. Phase 1 · Novartis Pharmaceuticals
• Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib Phase 2 · Kadmon Corporation, LLC
• Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Phase 4 · AstraZeneca
• High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC Phase 2 · Chinese Academy of Medical Sciences
• Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer Phase 2 · Institut Bergonié
• In Vitro NSCLC EGFR-Mutant Models for Drug Sensitivity Testing N/A · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
• Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma Phase 2 · Ulsan University Hospital
• A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Phase 3 · Hoffmann-La Roche

Related landscapes

• Phase 4 Carcinoma, Non-Small-Cell Lung
• Phase 2 Carcinoma, Non-Small-Cell Lung
• Phase 3 Carcinoma, Non-Small-Cell Lung
• N/A Carcinoma, Non-Small-Cell Lung
• Phase 1 Carcinoma, Non-Small-Cell Lung

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.